Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.

Literature DB >> 6805951

Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.

C Sessa, M D'Incalci, I Valente, G Bolis, N Colombo, C Mangioni.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 1982 PMID： 6805951

Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

Review 1. Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Authors: C R Lee; D Faulds
Journal: Drugs Date: 1995-06 Impact factor: 9.546

2. Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.

Authors: C Sessa; G Bolis; N Colombo; M D'Incalci; B Mermillod; I Valente; C Mangioni
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

2 in total